301 related articles for article (PubMed ID: 34212564)
1. The pathogenesis of bone metastasis in solid tumors: a review.
Vičić I; Belev B
Croat Med J; 2021 Jun; 62(3):270-282. PubMed ID: 34212564
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
3. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
4. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
5. Secreted microRNAs in bone metastasis.
Taipaleenmäki H
J Bone Miner Metab; 2023 May; 41(3):358-364. PubMed ID: 37031329
[TBL] [Abstract][Full Text] [Related]
6. Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis.
Haider MT; Ridlmaier N; Smit DJ; Taipaleenmäki H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809315
[TBL] [Abstract][Full Text] [Related]
7. CD8
Monteiro AC; Bonomo A
Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
[TBL] [Abstract][Full Text] [Related]
8. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
Kreps LM; Addison CL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
[TBL] [Abstract][Full Text] [Related]
9. Bone resorption and bone metastasis risk.
Mathis KM; Sturgeon KM; Winkels RM; Wiskemann J; De Souza MJ; Schmitz KH
Med Hypotheses; 2018 Sep; 118():36-41. PubMed ID: 30037612
[TBL] [Abstract][Full Text] [Related]
10. Osteocytes and Bone Metastasis.
Riquelme MA; Cardenas ER; Jiang JX
Front Endocrinol (Lausanne); 2020; 11():567844. PubMed ID: 33162934
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of bone metastasis.
Mundy GR
Cancer; 1997 Oct; 80(8 Suppl):1546-56. PubMed ID: 9362421
[TBL] [Abstract][Full Text] [Related]
12. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondins in bone remodeling and metastatic bone disease.
Carminati L; Taraboletti G
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
15. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
17. The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis.
Suominen MI; Wilson T; Käkönen SM; Scholz A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405099
[TBL] [Abstract][Full Text] [Related]
18. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
19. Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis.
Kang Y
Endocrinol Metab (Seoul); 2016 Jun; 31(2):206-12. PubMed ID: 27184014
[TBL] [Abstract][Full Text] [Related]
20. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]